217 results
8-K
EX-99.2
MDXG
Mimedx Group Inc
5 Jun 19
MiMedx Issues New Presentation for Investors in Advance of 2018 Annual Meeting
5:20pm
accounting issues required investigation before audited financial statements could be provided to shareholders In Q2 2018, the Audit Committee concluded … management and Anti-Kickback Statute and related allegations The Audit Committee launched an independent investigation, with the assistance of independent
8-K
MDXG
Mimedx Group Inc
23 May 19
MiMedx Announces Conclusion of Audit Committee’s Independent Investigation
5:15pm
a press release announcing the conclusion of the investigation of the Audit Committee (the “Audit Committee”) of the board of directors … in conducting an independent investigation into current and prior-period matters relating to allegations regarding certain sales and distribution practices
8-K
EX-99.1
MDXG
Mimedx Group Inc
23 May 19
MiMedx Announces Conclusion of Audit Committee’s Independent Investigation
5:15pm
Exhibit 99.1
MiMedx Announces Conclusion of Audit Committee’s Independent Investigation
Investigation Revealed Extensive Misconduct by Former … investigation (“the Investigation”) into matters relating to, among other things, allegations regarding certain sales and distribution practices
8-K
EX-99.1
MDXG
Mimedx Group Inc
6 Dec 18
Mimedx Announces Organizational Realignment Program
6:10am
, the Audit Committee’s independent investigation has required changes to business practices to address issues identified in the investigation … investigation is still ongoing, and there may be other actions taken based, at least in part, on information from the investigation. The Company continues
8-K
EX-99.1
MDXG
Mimedx Group Inc
11 Apr 19
MiMedx Announces Board Approval of Long-Range Strategic Plan
4:40pm
on Investigation and Other Matters
MARIETTA, Ga., April 11, 2019 — MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader … . The capital raise is also intended to provide liquidity to fund the costs associated with the ongoing Audit Committee investigation, the restatement
DEFA14A
55ibs1up q7xjrktz
5 Jun 19
Additional proxy soliciting materials
5:24pm
DFAN14A
tm7wca qmg9q8
2 May 19
Additional proxy materials by non-management
3:51pm
8-K
EX-99.1
wx94iz 1hs
18 Mar 20
MiMedx Announces Filing of 2018 Annual Report
12:00am
8-K
EX-99.2
r5ta ofbe0990
3 Jun 19
Other Events
8:52am
8-K
EX-99.1
mzjgvpwbd v0
26 Apr 18
Mimedx Reports Unreviewed First Quarter Revenue Exceeds Upper End of Its Guidance
9:06am
8-K
EX-99.1
p1wnbn6vn 32r
20 Sep 18
Mimedx Provides Update on Previously Announced Senior Executive Separations
5:17pm
DEFA14A
mssle05v
3 Jun 19
Additional proxy soliciting materials
5:22pm
8-K
EX-99.1
um7mz bufss
6 Apr 20
MiMedx Announces Settlement of VA Pricing Investigation
1:04pm
8-K
EX-99.1
gk0 ea9ekkibz9
3 Jun 19
Other Events
8:52am
DEFA14A
c1qy1m664tf 9h8q
3 Jun 19
Additional proxy soliciting materials
9:39pm
DFAN14A
g97ps
6 Jun 19
Additional proxy materials by non-management
5:20pm
8-K
EX-99.1
ytbbxk8cqj
28 Feb 24
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
4:22pm
8-K
EX-99.1
9x1w6
4 Nov 20
MiMedx Announces Third Quarter 2020 Financial Results
4:14pm
8-K
EX-99.1
u5knydag65s wxsxrc
30 Apr 24
MIMEDX Announces First Quarter 2024 Operating and Financial
4:10pm
8-K
EX-99.1
7lz18c p58g
30 Oct 23
MIMEDX Announces Third Quarter 2023 Operating and Financial Results
4:05pm